Luye Pharma Group Ltd.

SEHK:2186 주식 보고서

시가총액: HK$12.6b

이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Luye Pharma Group 관리

관리 기준 확인 3/4

현재 CEO에 대한 정보가 충분하지 않습니다.

주요 정보

Dian Bo Liu

최고 경영자

CN¥4.2m

총 보상

CEO 급여 비율75.1%
CEO 임기21.3yrs
CEO 소유권n/a
경영진 평균 재임 기간12.8yrs
이사회 평균 재임 기간10.3yrs

최근 관리 업데이트

We Discuss Why Luye Pharma Group Ltd.'s (HKG:2186) CEO Compensation May Be Closely Reviewed

May 21
We Discuss Why Luye Pharma Group Ltd.'s (HKG:2186) CEO Compensation May Be Closely Reviewed

Recent updates

Unpleasant Surprises Could Be In Store For Luye Pharma Group Ltd.'s (HKG:2186) Shares

Sep 25
Unpleasant Surprises Could Be In Store For Luye Pharma Group Ltd.'s (HKG:2186) Shares

Does Luye Pharma Group (HKG:2186) Have A Healthy Balance Sheet?

Aug 29
Does Luye Pharma Group (HKG:2186) Have A Healthy Balance Sheet?

Luye Pharma Group Ltd.'s (HKG:2186) Earnings Haven't Escaped The Attention Of Investors

Jun 19
Luye Pharma Group Ltd.'s (HKG:2186) Earnings Haven't Escaped The Attention Of Investors

We Discuss Why Luye Pharma Group Ltd.'s (HKG:2186) CEO Compensation May Be Closely Reviewed

May 21
We Discuss Why Luye Pharma Group Ltd.'s (HKG:2186) CEO Compensation May Be Closely Reviewed

Here's Why Luye Pharma Group (HKG:2186) Has A Meaningful Debt Burden

Apr 26
Here's Why Luye Pharma Group (HKG:2186) Has A Meaningful Debt Burden

Is Luye Pharma Group Ltd. (HKG:2186) Trading At A 27% Discount?

Feb 29
Is Luye Pharma Group Ltd. (HKG:2186) Trading At A 27% Discount?

Some Confidence Is Lacking In Luye Pharma Group Ltd.'s (HKG:2186) P/S

Jan 09
Some Confidence Is Lacking In Luye Pharma Group Ltd.'s (HKG:2186) P/S

Luye Pharma Group (HKG:2186) Takes On Some Risk With Its Use Of Debt

Dec 19
Luye Pharma Group (HKG:2186) Takes On Some Risk With Its Use Of Debt

A Look At The Fair Value Of Luye Pharma Group Ltd. (HKG:2186)

Nov 24
A Look At The Fair Value Of Luye Pharma Group Ltd. (HKG:2186)

Is Luye Pharma Group (HKG:2186) A Risky Investment?

Sep 12
Is Luye Pharma Group (HKG:2186) A Risky Investment?

Luye Pharma Group Ltd.'s (HKG:2186) Intrinsic Value Is Potentially 20% Below Its Share Price

Aug 17
Luye Pharma Group Ltd.'s (HKG:2186) Intrinsic Value Is Potentially 20% Below Its Share Price

Is Luye Pharma Group (HKG:2186) Using Too Much Debt?

May 10
Is Luye Pharma Group (HKG:2186) Using Too Much Debt?

We Think Luye Pharma Group (HKG:2186) Is Taking Some Risk With Its Debt

Sep 20
We Think Luye Pharma Group (HKG:2186) Is Taking Some Risk With Its Debt

Time To Worry? Analysts Just Downgraded Their Luye Pharma Group Ltd. (HKG:2186) Outlook

Apr 06
Time To Worry? Analysts Just Downgraded Their Luye Pharma Group Ltd. (HKG:2186) Outlook

Luye Pharma Group's (HKG:2186) Shareholders Are Down 31% On Their Shares

Mar 17
Luye Pharma Group's (HKG:2186) Shareholders Are Down 31% On Their Shares

CEO 보상 분석

Dian Bo Liu 의 보수는 Luye Pharma Group 의 수익과 비교하여 어떻게 변경되었나요?
날짜총 보상급여회사 수익
Jun 30 2024n/an/a

CN¥770m

Mar 31 2024n/an/a

CN¥652m

Dec 31 2023CN¥4mCN¥3m

CN¥533m

Sep 30 2023n/an/a

CN¥495m

Jun 30 2023n/an/a

CN¥458m

Mar 31 2023n/an/a

CN¥531m

Dec 31 2022CN¥3mCN¥3m

CN¥605m

Sep 30 2022n/an/a

CN¥190m

Jun 30 2022n/an/a

-CN¥224m

Mar 31 2022n/an/a

-CN¥179m

Dec 31 2021CN¥4mCN¥3m

-CN¥134m

Sep 30 2021n/an/a

CN¥210m

Jun 30 2021n/an/a

CN¥554m

Mar 31 2021n/an/a

CN¥630m

Dec 31 2020CN¥5mCN¥4m

CN¥707m

Sep 30 2020n/an/a

CN¥955m

Jun 30 2020n/an/a

CN¥1b

Mar 31 2020n/an/a

CN¥1b

Dec 31 2019CN¥4mCN¥3m

CN¥1b

Sep 30 2019n/an/a

CN¥1b

Jun 30 2019n/an/a

CN¥1b

Mar 31 2019n/an/a

CN¥1b

Dec 31 2018CN¥4mCN¥3m

CN¥1b

Sep 30 2018n/an/a

CN¥1b

Jun 30 2018n/an/a

CN¥1b

Mar 31 2018n/an/a

CN¥1b

Dec 31 2017CN¥4mCN¥3m

CN¥981m

보상 대 시장: Dian Bo 의 총 보상 ($USD 575.76K )은 Hong Kong 시장에서 비슷한 규모의 회사의 평균 수준입니다( $USD 486.88K ).

보상과 수익: Dian Bo 의 보상은 지난 1년 동안 20% 이상 증가했습니다.

CEO

Dian Bo Liu (58 yo)

21.3yrs

테뉴어

CN¥4,180,000

보상

Mr. Dian Bo Liu is a Co-Founder of Luye Pharma Group Ltd. in 1994 and serves as its Head of Corporate Directions & Strategies and has been its Chief Executive Officer since July 2003. Mr. Liu is responsibl...

리더십 팀

이름위치테뉴어보상소유권
Dian Bo Liu
Co-Founder21.3yrsCN¥4.18m데이터 없음
Rong Bing Yang
Co-Founder & Vice Executive Chairman21.3yrsCN¥3.09m데이터 없음
Hui Xian Yuan
Co-Founder & Executive Directorno dataCN¥1.46m데이터 없음
Yuan Yuan Zhu
Executive Directorno dataCN¥1.50m데이터 없음
Yuan Chong Liu
Chief Financial Officer12.8yrs데이터 없음데이터 없음
Mei Yi Lee
Company Secretary3.8yrs데이터 없음데이터 없음

12.8yrs

평균 재임 기간

58yo

평균 연령

경험이 풍부한 관리: 2186 의 관리팀은 노련하고 경험 (평균 재직 기간 12.4 년)입니다.

이사회 구성원

이름위치테뉴어보상소유권
Dian Bo Liu
Co-Founder21.3yrsCN¥4.18m데이터 없음
Rong Bing Yang
Co-Founder & Vice Executive Chairman21.3yrsCN¥3.09m데이터 없음
Hui Xian Yuan
Co-Founder & Executive Director21.3yrsCN¥1.46m데이터 없음
Yuan Yuan Zhu
Executive Director10.6yrsCN¥1.50m데이터 없음
Yuk Lam Lo
Independent Non-Executive Director10.3yrsCN¥269.00k데이터 없음
Man Kit Leung
Independent Non-Executive Director10.3yrsCN¥322.00k데이터 없음
Rui Lin Song
Non-Executive Director7.6yrsCN¥269.00k데이터 없음
Sze Chung Choy
Independent Non-Executive Director10.3yrsCN¥269.00k데이터 없음
Huaqiao Zhang
Independent Non-Executive Director10.3yrsCN¥269.00k데이터 없음
Dong Lyu
Non-Executive Directorless than a year데이터 없음데이터 없음
Lian Xia
Independent Non-Executive Director1.4yrsCN¥162.00k데이터 없음

10.3yrs

평균 재임 기간

61yo

평균 연령

경험이 풍부한 이사회: 2186 의 이사회는 노련하고 경험이 있습니다(평균 재직 기간 10 년).